← All sarcoma trials
Recruiting now—Ages 18 Years to 85 Years

Molecular Mechanisms in Malignant Lymphoma- Predict (MMML Predict)

Sponsor: University Medical Center Goettingen · NCT06526065 on ClinicalTrials.gov ↗

Bring this to your care team →

Conditions studied

DLBCL - Diffuse Large B Cell Lymphoma

What it tests

  • no interventionother

Where it's running1 site

1 international site

  • Universitätsmedizin Göttingen

    Göttingen, Lower Saxony, Germany 37075

    Recruiting now
    • Anna-Carina Hund(contact)
See the official eligibility language

Shown exactly as written on ClinicalTrials.gov. Your oncologist is the right person to judge whether it fits your situation.

Inclusion Criteria:

1. Histological diagnosis of DLBCL\&LBCL
2. Planned treatment with guideline-based first-line therapy
3. Patient's consent
4. All genders, Patient age ≥ 18 years
5. Ability to consent

Exclusion Criteria:

1. Treatment with R-CHOP/-like regimens already started
2. Relationship of dependence/ direct employment with the investigator
3. Active HIV-infection
4. Presence history of other active cancers (with the exception of basal cell carcinoma of the skin)

Updated 2024-07-29 on ClinicalTrials.gov. Always confirm current details with the study team or your oncologist.